Floatz logo

Docetaxel

Peritoneal Neoplasms

Clinica Universidad de Navarra, Universidad de NavarraSmall moleculePhase 3Active
B
62/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
52/ 100
Competitive Position
81/ 100

Competitive context

17 Active assets in the Peritoneal Neoplasms cohort.

Asset / SponsorPhaseRating
Carboplatin
Eli Lilly and Company
Phase 3BBB
Inno-206
Eli Lilly and Company
Phase 3BBB
Eloxatin
Sun Yat-sen University
Phase 2/3BB
Hycamtin
Eli Lilly and Company
Phase 3BB
Patupilone
Novartis Pharmaceuticals
Phase 3BB

View all 44 →

Same molecule, other indications

Docetaxel is also rated in:

prostate neoplasmDormant
BBB
Indicative ·
73 / 100
View asset →
pancreatic adenocarcinomaDormant
BBB
Indicative ·
72 / 100
View asset →
cancer of unknown primary siteDormant
BBB
Indicative ·
72 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →